Gilead Sciences has been knocked back in its quest to bring the first drug therapy for hepatitis D virus (HDV ... unusual in that it exists only as a co-infection with hepatitis B virus (HBV ...

Approximately 4–5 million HIV-infected patients are coinfected with HCV. HIV–HCV coinfection is associated with a higher HCV RNA load and rapid disease progression to cirrhosis compared with ...

Coinfection with hepatitis B virus (HBV) is common in the human immunodeficiency virus-1 (HIV)-infected patient because of shared modes of transmission. HBV does not appear to alter HIV disease ...

The types of viral hepatitis include: Hepatitis A is: Hepatitis B is: Hepatitis C is: Hepatitis D is: Hepatitis E is: Vaccinations are available for the prevention of hepatitis A and B but not types C ...

An all-encompassing guide to understanding hepatitis. Alcohol and acetaminophen are well-known liver dangers, but what else can be harmful? WebMD says some of them may surprise you. It has 500 ...

Additionally, the hepatitis D virus (HDV), an enveloped RNA satellite virus that uses HBV surface proteins in HBV/HDV co-infection, enhances the severity of liver disease. NTCP (SLC10A1), involved in ...

Vir Biotechnology, Inc. (NASDAQ:VIR) today announced it will present new data from the Phase 2 SOLSTICE clinical trial ...

The hidden strength of CD8 + T cells in chronic hepatitis B A distinct subset of attenuated CD8 + T cells that retain crucial cytotoxic functions has been identified in chronic hepatitis B ...

There are no specific treatments for hepatitis A, a liver disease that’s caused by the hepatitis A virus and marked by inflammation of the liver. The virus is most often transmitted via ...

Healthcare professionals administer the hepatitis A vaccine in two doses. They give the first dose when the infant is between 12 and 23 months old and the second dose 6 months after the first.

Most pediatric cases of hepatitis C virus (HCV) infection are perinatal, meaning the virus is transmitted from birthing ...

M.D., M.P.H., Executive Vice President and Chief Medical Officer, Vir Biotechnology. “Further, patients living with chronic hepatitis B face lifelong treatment and an increased risk of cirrhosis ...